← Back to Clinical Trials
Recruiting NCT07097454

NCT07097454 Effectiveness of Hypotension Prediction Index (HPI) in Preventing Hypotension in the Post-Anesthesia Care Unit (PACU)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07097454
Status Recruiting
Phase
Sponsor Wonkwang University Hospital
Condition Hypotension
Study Type INTERVENTIONAL
Enrollment 210 participants
Start Date 2026-07-02
Primary Completion 2026-07-30

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Hypotension Prediction Index MonitoringStandard PACU Monitoring

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 210 participants in total. It began in 2026-07-02 with a primary completion date of 2026-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Postoperative hypotension in the post-anesthesia care unit (PACU) is common and linked to adverse outcomes. The Hypotension Prediction Index (HPI) predicts hypotensive events intraoperatively, but its PACU application is unexplored. This study aims to investigate the effectiveness of HPI-guided monitoring in preventing PACU hypotension.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 19 years * Undergoing elective surgery under general anesthesia * Presence of intra-arterial catheter at the end of surgery * Expected PACU stay of ≥ 30 minutes * Provided written informed consent Exclusion Criteria: * Immediate postoperative ICU admission * Use of vasopressors during emergence from anesthesia * ASA physical status classification of V * Known contraindications to arterial line placement * Participation in another interventional study within 30 days

Contact & Investigator

Central Contact

Cheol Lee, M.D.,Ph.D.

✉ ironyii@wku.ac.kr

📞 +82-1066131252

Principal Investigator

Cheol Lee, M.D.,Ph.D

PRINCIPAL INVESTIGATOR

Department of anesthesiology and pain medicine, Wonkwang University Hospital

Frequently Asked Questions

Who can join the NCT07097454 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Hypotension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07097454 currently recruiting?

Yes, NCT07097454 is actively recruiting participants. Contact the research team at ironyii@wku.ac.kr for enrollment information.

Where is the NCT07097454 trial being conducted?

This trial is being conducted at Iksan, South Korea.

Who is sponsoring the NCT07097454 clinical trial?

NCT07097454 is sponsored by Wonkwang University Hospital. The principal investigator is Cheol Lee, M.D.,Ph.D at Department of anesthesiology and pain medicine, Wonkwang University Hospital. The trial plans to enroll 210 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology